These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23117977)

  • 1. The COPD control panel: towards personalised medicine in COPD.
    Agusti A; MacNee W
    Thorax; 2013 Jul; 68(7):687-90. PubMed ID: 23117977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.
    Lopez-Campos JL; Bustamante V; Muñoz X; Barreiro E
    COPD; 2014 Sep; 11(5):591-602. PubMed ID: 24914771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global assessment of the COPD patient: time to look beyond FEV1?
    Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
    Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?
    Vestbo J; Hurd SS; Rodriguez-Roisin R
    Clin Respir J; 2012 Oct; 6(4):208-14. PubMed ID: 22906068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The path to personalised medicine in COPD.
    Agusti A
    Thorax; 2014 Sep; 69(9):857-64. PubMed ID: 24781218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and management of chronic obstructive pulmonary disease].
    Sato N; Kanazawa M
    Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung function test for COPD].
    Itabashi S
    Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
    Jones PW; Agusti AG
    Eur Respir J; 2006 Apr; 27(4):822-32. PubMed ID: 16585091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
    Barczyk A; Pierzchała W
    Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.
    van der Molen T; Diamant Z; Kocks JW; Tsiligianni IG
    Expert Rev Respir Med; 2014 Aug; 8(4):479-91. PubMed ID: 24894492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2007 GOLD Guidelines: a comprehensive care framework.
    Gold PM
    Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
    Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
    Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severity of COPD--a broader prognostic assessment is necessary].
    Puhan M
    Praxis (Bern 1994); 2007 Nov; 96(48):1901-5. PubMed ID: 18072580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD exacerbations . 3: Pathophysiology.
    O'Donnell DE; Parker CM
    Thorax; 2006 Apr; 61(4):354-61. PubMed ID: 16565268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
    Zuwallack RL; Nici L
    COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities].
    Martín-Escudero JC
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():13-21. PubMed ID: 21596169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
    Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
    Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.